Codes / ICD10CM / T47.0X5A

T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of histamine H2-receptor blockers, initial encounter

Summary

This condition describes harmful reactions resulting from exposure to histamine H2-receptor blockers, a class of medications used to reduce stomach acid production. It specifically denotes an adverse effect during the initial encounter, distinguishing it from poisoning, underdosing, or subsequent encounters. The reaction may occur at therapeutic doses or due to unintended interactions.

Causes

Adverse effects can arise from therapeutic use of H2-receptor blockers, including unintended reactions to the medication or interactions with other substances. The condition may result from individual sensitivity, dosage, or formulation, even when the medication is used as prescribed.

Risk Factors

  • Risk factors include polypharmacy (use of multiple medications), underlying conditions affecting drug metabolism, and individual susceptibility to adverse reactions. Older adults or those with impaired kidney or liver function may be more susceptible.

Symptoms

  • Symptoms may include headache, rash, dizziness, gastrointestinal distress (e.g., nausea, vomiting, abdominal pain), or more severe systemic effects depending on the dose and individual response. Reactions can vary in severity and presentation.

Diagnosis

Diagnosis involves reviewing the patient's medication history, conducting a physical examination, and assessing the temporal relationship between medication use and symptom onset. Laboratory tests may be used to rule out other causes or confirm the adverse effect.

Treatment Options

Treatment focuses on managing symptoms and discontinuing the offending medication if appropriate. Supportive care, such as hydration or antiemetics, may be provided. In severe cases, additional interventions may be necessary based on the specific reaction.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and timely intervention. Most adverse effects resolve with discontinuation of the medication and supportive care. Follow-up may involve monitoring for resolution of symptoms and adjusting treatment plans to avoid recurrence.

Complications

Complications can include prolonged symptoms, secondary infections (e.g., from gastrointestinal distress), or systemic effects if the reaction is severe. Rarely, severe reactions may require hospitalization or intensive care.

Lifestyle & Prevention

Prevention involves using medications as prescribed, avoiding known allergens or sensitivities, and communicating openly with healthcare providers about all medications and supplements. Proper storage and adherence to dosing instructions can reduce risk.

When to Seek Professional Help

Seek medical attention if symptoms are severe, worsening, or accompanied by signs of an allergic reaction (e.g., difficulty breathing, swelling). Prompt evaluation is important for managing adverse effects and preventing complications.

Tips for Medical Coders

Document the specific histamine H2-receptor blocker involved, the nature of the adverse effect, and the encounter type (initial). Ensure the diagnosis aligns with clinical findings and medication history. Code T47.0X5A is used for initial encounters with adverse effects of these medications.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T47.0X5A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.